Germ cell tumors of the testis overexpress wild-type p53

American Journal of Pathology

Volumn 149, Issue 4, 1996, Pages 1221-1228

  Guillou, Louis ^a   Estreicher, Anne ^c   Chaubert, Pascal ^a   Hurlimann, Jean ^a   Kurt, Anne Marie ^b   Metthez, Geneviève ^a   Iggo, Richard ^c   Gray, Anne C ^a   Jichlinski, Patrice ^d   Leisinger, Hans Jürg ^d   Benhattar, Jean ^a  

^a UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; GENE MUTATION; GERM CELL TUMOR; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; GERMINOMA; HUMANS; MALE; TESTICULAR NEOPLASMS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; YEASTS;

EID: 10144247897     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Deppert W: The yin and yang of p53 in cellular proliferation. Semin Cancer Biol 1994, 5:187-202
2. Oren M: Relationship of p53 to the control of apoptotic cell death. Semin Cancer Biol 1994, 5:221-227
3. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 1991, 253:49-53
4. Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 1993, 329: 1318-1327
5. Iggo R, Gatter K, Bartek J, Lane D: Increased expression of mutant form of p53 oncogene in primary lung cancer. Lancet 1990, 335:675-679
6. Legros Y, Meyer A, Ory K, Soussi T: Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the protein. Oncogene 1994, 9:3689-3694
7. Hurlimann J, Chaubert P, Benhattar J: P53 gene alterations, and p53 protein accumulation in infiltrating ductal breast carcinomas: correlation between immunohistochemical and molecular biology techniques. Mod Pathol 1994, 7:423-428
8. Tenaud C, Negoescu A, Labat-Moleur F, Legros Y, Soussi T, Brambilla E. p53 immunolabeling in archival paraffin-embedded tissues: optimal protocol based on microwave heating for eight antibodies on lung carcinoma. Mod Pathol 1994, 7:853-859
9. Bartkova J, Bartek J, Lukas J, Vojtesek B, Staskova Z, Rejthar A, Kovarik J, Midgley CA, Lane DP: p53 protein alterations in human testicular cancer including preinvasive intratubular germ-cell neoplasia. Int J Cancer 1991, 49:196-202
10. Korman HJ, Schultz DS, Linden MD, Miles BJ, Peabody JO: Proliferating cell nuclear antigen and mutant p53 staining in testicular nonseminomatous germ-cell tumors: a pilot study. J Urol Pathol 1994, 2:327-336
11. Ulbright TM, Orazi A, de Riese W, de Riese C, Messemer JE, Foster RS, Donohue JP, Eble JN: The correlation of p53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis. Mod Pathol 1994, 7:64-68
12. Riou G, Barrois M, Prost S, Terrier MJ, Theodore C, Levine AJ: The p53 and mdm2 genes in human testicular germ-cell tumors. Mol Carcinogen 1995, 12:124-131
13. Schenkman: NS, Sesterhenn IA, Washington L, Tong YA, Weghorst CM, Buzard GS, Srivastava S, Moul JW: Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors. J Urol 1995, 154:617-621
14. Lewis DJ, Sesterhenn IA, McCarthy WF, Moul JW: Immunohistochemical expression of p53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease. J Urol 1994, 152: 418-423
15. Peltomäki P, Alfthan O, De la Chapelle A: Oncogenes in human testicular cancer: DNA and RNA studies. Br J Cancer 1991, 63:851-858
16. Fleischhacker M, Strohmeyer T, Imai Y, Slamon DJ, Koeffler HP: Mutations of the p53 gene are not detectable in human testicular tumors. Mod Pathol 1994, 7:435-439
17. Peng HQ, Hogg D, Malkin D, Bailey D, Gallie BL, Bulbul M, Jewett M, Buchanan J, Goss PE: Mutations of the p53 gene do not occur in testis cancer. Cancer Res 1993, 53:3574-3578
18. Heimdal K, Lothe RA, Lystad S, Holm R, Fossa SD, Berresen AL: No germline TP53 mutations detected in familial and bilateral testicular cancer. Genes Chromosomes & Cancer 1993, 6:92-97
19. Flaman JM, Frebourg T, Moreau V, Charbonnier F, Martin C, Chappuis P, Sappino AP, Limacher JM, Rustgi AK, Bron L, Benhattar J, Tada M, Estreicher A, Iggo RD: A simple p53 functional assay for screening cell lines, blood, and tumors. Proc Natl Acad Sci USA 1995, 92:3963-3967
20. EI-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B: Waf1/Cip1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994, 54:1169-1174
21. Ulbright T: Germ cell neoplasms of the testis. Am J Surg Pathol 1993, 17:1075-1091
22. Burke AP, Mostofi FK: Placental alkaline phosphatase immunohistochemistry of intratubular malignant germ cells and associated testicular germ cell tumors. Hum Pathol 1988, 19:663-670
23. Hsu SM, Raine L, Fanger H: Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580
24. Hurlimann J, Saraga EP: Expression of p53 protein in gastric carcinomas. Am J Surg Pathol 1994, 18:1247-1253
25. Gannon JV, Greaves R, Iggo R, Lane DP: Activating mutations in p53 produce a common conformational effect: a monoclonal antibody specific for the mutant form. EMBO J 1990, 9:1595-1602
26. Banks L, Matlashewski G, Crawford L: Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem 1986, 159:529-534
27. Stephen CW, Lane DP: Mutant conformation of p53: precise epitope mapping using a filamentous phage epitope library. J Mol Biol 1992, 225:577-583
28. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D, Barnes DM: Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli. J Cell Sci 1992, 101:183-189
29. Losi L, Benhattar J, Costa J: Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer 1992, 28:1115-1120
30. Chaubert P, Bautista D, Benhattar J: An improved method for rapid screening of DNA mutations by non-radioactive single-strand conformation polymorphism procedure. Biotechniques 1993, 15:586
31. Flaman JM, Waridel F, Estreicher A, Vannier A, Limacher JM, Gilbert D, Iggo R, Frebourg T: The human p53 gene is alternatively spliced in normal cells. Oncogene 1996, 12:813-818
32. Serth J, Kuczyk MA, Derendorf L, Jonasson J, Allhoff EP, Jonas U: Identification of frequent p53 gene alterations in testicular cancer by in situ molecular genetic and immunohistochemical analysis. J Urol 1994, 151: 408A
33. Inoue M, Fujita M, Enomoto T, Morimoto H, Monden T, Shimano T, Tanizawa O: Immunohistochemical analysis of p53 in gynecologic tumors. Am J Clin Pathol 1994, 102:665-670
34. Kuczyk MA, Serth J, Bokemeyer C, Allhoff EP, Jonassen J, Kuczyk S, Jonas U: Overexpression of the p53 oncoprotein in carcinoma in situ of the testis. Pathol Res Pract 1994, 190:993-998
35. Wei YD, Jiafu Z, Xi QS, Yongjiang M, Xiulong Z, Daizong L, Jianren G: p53 gene mutations in Chinese human testicular seminoma. J Urol 1993, 150:884-886
36. Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW: High frequency of p53 protein accumulation without p53 mutation in human juvenile pilocytic, low grade, and anaplastic astrocytomas. Oncogene 1994, 9:949-954
37. Louis DN, von Deimling A, Chung RY, Rubio MP, Whaley JM, Eibl RH, Ohgaki H, Wiestler OD, Thor AD, Seizinger BR: Comparative study of p53 gene and protein alterations in human astrocytomas. J Neuropathol Exp Neurol 1993, 52:31-38
38. Kupryjanczyk J, Thor AD, Beauchamp R, Merritt V, Edgerton SM, Bell DA, Yandell DW: p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci USA 1993, 90:4961-4965
39. Ambros RA, Ross JS, Kallakury BVS, Malfetano J, Kim Y, Hwang J, Breese K, Figge J: p53 gene status in endometrial carcinomas showing diffuse positivity for p53 protein by immunohistochemical analysis. Mod Pathol 1995, 8:441-445
40. Lohmann D, Ruhri C, Schmitt M, Graeff H, Höfler H: Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Diagn Mol Pathol 1993, 2:36-41
41. Kennedy SM, Macgeogh C, Jaffe R, Spurr NK: Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations. Hum Pathol 1994, 25:438-442
42. Xu L, Chen YT, Huvos AG, Zlotolow IM, Rettig WJ, Old LJ, Garin-Chesa P: Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations. Diagn Mol Pathol 1994, 3:83-92
43. Marchetti A, Buttitta F, Pellegrini S, Merlo G, Chella A, Angeletti CA, Bevilacqua G: mdm2 gene amplification and overexpression in non-small cell lung carcinomas with accumulation of the p53 protein in the absence of p53 gene mutations. Diagn Mol Pathol 1995, 4:93-97
44. Cesarman E, Inghirami G, Chadburn A, Knowles DM: High levels of p53 protein expression do not correlate with p53 gene mutations in anaplastic large cell lymphoma. Am J Pathol 1993, 143:845-856
45. Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992, 69:1237-1245
46. Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C: Wild-type p53 activates transcription in vitro. Nature 1992, 358:83-86
47. Mietz JA, Unger T, Huibregtse J M, Howley PM: The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J 1992, 11:5013-5020
48. Yew PR, Berk AJ: Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 1992, 357:82-85
49. Hermeking H, Funk J, Reichert M, Ellwart J, Eick D: Abrogation of p53-induced cell cycle arrest by c-myc: evidence for an inhibitor of p21. Oncogene 1995, 11: 1409-1415
50. Mora PT, Chandrasekaran K, McFarland VW: An embryo protein induced by SV40 virus transformation of mouse cells. Nature 1980, 288:722-724
51. Schwartz D, Goldfinger N, Rotter V: Expression of p53 protein in spermatogenesis is confined to the tetraploid pachytene primary spermatocytes. Oncogene 1993, 8:1487-1494